SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is seeing renewed momentum driven by strong prescription data and positive sentiment surrounding the oral Wegovy rollout, which is being viewed as a strategic advantage against competitors. Investors are closely watching the upcoming earnings report, with community discussions heavily focused on the company's ability to maintain its market position through potential M&A and improved guidance.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently experiencing heightened retail activity and speculative momentum driven by its integration into the broader Japanese blockchain and IoT data economy narratives. While the community is actively debating the potential impact of ecosystem expansions like Janction, sentiment remains divided between long-term holders accumulating positions and skeptics focused on historical price underperformance.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing significant momentum and retail interest as investors connect the company's specialized MRAM technology to broader AI memory and aerospace growth narratives. Market participants are actively debating the sustainability of this rapid move, with bulls pointing to recent defense contracts and low float as catalysts for a potential squeeze, while some skeptics express concerns over high valuations and technical resistance.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as shareholders react to reports that FDA Commissioner Marty Makary may be replaced, a move widely interpreted by the community as a positive catalyst that could alleviate regulatory friction for the company's oncology pipeline. Investors are actively discussing the potential for smoother sBLA reviews and increased global expansion, fueling bullish sentiment despite recent volatility and ongoing legal disputes.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following an FDA meeting to define the pivotal Phase 3 registration path for CAD-1005 in treating heparin-induced thrombocytopenia, though community sentiment remains polarized due to concerns over high-frequency social media spamming and future dilution risks.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Abbott Laboratories is experiencing significant downward pressure as investors weigh disappointing earnings guidance and the financial implications of its recent acquisition of Exact Sciences. The community is actively debating whether the current price levels represent a deep-value buying opportunity or a value trap amid ongoing litigation concerns and broader institutional de-risking within the healthcare sector.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF (SNDQ) is seeing significant volume and trader attention as market participants attempt to hedge against the rapid, parabolic price appreciation in SanDisk (SNDK). The community is actively debating the sustainability of the semiconductor sector's momentum, with many users employing SNDQ as a tactical vehicle to bet on a potential correction or reversal.

X-Energy, Inc. operates as an energy company The firm focuses on modular nuclear reactors and fuel technology for clean energy generation. The company was founded by Kam Ghaffarian and Eben Mulder on 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-energy Inc

X-energy is trending following a successful IPO that saw significant interest due to its strategic backing by Amazon and its position as a key infrastructure player in the AI power-demand narrative. The community is actively debating the company's valuation compared to peers, with investors highlighting the company's industrial partnerships and proprietary TRISO fuel technology as major differentiators for long-term scalability.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

Internet Computer (ICP) is currently a focal point for investors debating its long-term infrastructure value versus its recent price volatility, with community sentiment split between frustration over performance and optimism surrounding its sovereign cloud capabilities and ongoing network burn. Discussions are dominated by speculation about future government partnerships and the impact of tokenomic updates, as traders monitor whether it can maintain structural support levels amidst broader market pressure.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as market participants closely monitor the iShares 20+ Year Treasury Bond ETF amid heightened geopolitical tensions in the Middle East and ongoing debates over Federal Reserve interest rate policy. Community sentiment remains split between those positioning for a long-term recession and deflationary impulse, and those wary of persistent inflation and rising Treasury yields driven by government spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Microvision (MVIS) to Release Quarterly Earnings on Friday

Microvision (NASDAQ:MVIS) will be releasing its Q1 2026 earnings after the market closes on Friday, May 8. (View Earnings Report at...

18 Shocking Facts That Prove The US Economy Is In Far Worse Shape Than Most People Realize

18 Shocking Facts That Prove The US Economy Is In Far Worse Shape Than Most People Realize Authored by Michael Snyder via The Economic Collapse blog, The economy has been the number one issue for...

Microvision (MVIS) to Release Quarterly Earnings on Wednesday

Microvision (NASDAQ:MVIS) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 25. (View Earnings Report at...

Microvision (NASDAQ:MVIS) Rating Lowered to Strong Sell at Wall Street Zen

Wall Street Zen lowered shares of Microvision from a "hold" rating to a "strong sell" rating in a report on Saturday...

<ul class="summary-bullets"><li>Microvision’s Q4 revenue slumped 88% year-on-year to $0.2 million with a loss per share of $0.12.</li><li>D. Boral Capital analyst Jesse Sobelson downgraded MicroVision to ‘Hold’ from ‘Buy’.</li><li>The analyst said the results underscore ongoing uncertainty around near-term sales growth and continued spending pressures.&nbsp;</li></ul>MicroVision Inc. (MVIS) saw its outlook turn more cautious on Wall Street after D. Boral Capital’s downgrade raised concerns about the company’s financial trajectory and uncertain revenue prospects.&nbsp;The shift follows the firm’s fourth-quarter (Q4) results. Microvision’s Q4 revenue slumped 88% year-on-year (YoY) to $0.2 million with a loss per share (EPS) of $0.12. Both revenue and EPS missed the analysts’ consensus estimates of $3 million and a loss per share of $0.05, according to Fiscal AI data.&nbsp;<h2 class="st-heading-2">Concerns Around Revenue Visibility</h2>D. Boral Capital analyst Jesse Sobelson downgraded MicroVision to ‘Hold’ from ‘Buy’ after reviewing the company’s Q4 performance and financial outlook. The analyst said the results underscore ongoing uncertainty around near-term sales growth and continued spending pressures.&nbsp;Sobelson said the company currently provides limited clarity about when meaningful revenue growth might materialize. While MicroVision has positioned its technology for potential applications in advanced sensing and automotive systems, the analyst suggested that tangible commercial traction has yet to fully emerge.<a href="https://stocktwits.com/symbol/MVIS/news">MicroVision stock</a> traded over 19% lower at noon Thursday. On Stocktwits, retail sentiment around the stock shifted to ‘neutral’ from ‘bearish’ territory the previous day. Message volume changed to ‘high’ from ‘normal’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_05_121054_png_4dd819fb08.webp" alt="MVIS’s Sentiment Meter and Message Volume as of 12:00 p.m. ET on Mar. 5, 2026 | Source: Stocktwits" width="929" height="102"></figure><h2 class="st-heading-2">Financial Performance And Liquidity</h2>The company recorded a quarterly net loss of $37.8 million, including significant non-cash impairment and inventory charges. By comparison, the loss for the prior-year quarter stood at $31.2 million.&nbsp;The lidar developer outlined a series of operational initiatives, including early product shipments, new technology integration, and plans to streamline costs as it prepares for future growth.MicroVision ended the year with approximately $74.8 million in cash and investment securities. In February 2026, the company further strengthened its balance sheet by issuing $43 million in senior secured convertible notes under an agreement with High Trail Capital.MVIS stock has declined by more than 53% over the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/paramount-skydance-ceo-david-ellison-says-wbd-deal-positions-it-to-compete-more-effectively-globally-report/cZdQDDQRI3k">Paramount Skydance CEO David Ellison Says WBD Deal Positions It To Compete More Effectively Globally: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the MicroVision logo is seen displayed on a smartphone screen. 

MVIS Plummets Over 20%: D. Boral Capital Downgrades The Stock Citing Revenue Uncertainty And Wider Q4 Loss

Analyst Jesse Sobelson said the company currently provides limited clarity about when meaningful revenue growth might materialize.

Equity

Analyst Jesse Sobelson said the company currently provides limited clarity about when meaningful revenue growth might materialize.


Microvision's (MVIS) "Hold" Rating Reaffirmed at D. Boral Capital

D. Boral Capital reissued a "hold" rating on shares of Microvision in a report on Thursday...

Microvision Q4 Earnings Call Highlights

Microvision (NASDAQ:MVIS) executives used the company's fourth-quarter and full-year 2025 earnings call to outline what Chief Executive Officer Glen DeVos described as a shift in the lidar industry...

Microvision (NASDAQ:MVIS) Releases Earnings Results, Misses Estimates By $0.07 EPS

Microvision (NASDAQ:MVIS - Get Free Report) posted its earnings results on Wednesday. The electronics maker reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.07...

Insights Ahead: Microvision's Quarterly Earnings

MicroVision Calls It Lidar 2.0, Highlights Luminar Deal and First Shipment to Europe

Microvision (NASDAQ:MVIS) executives used a recent webinar to outline what CEO Glen De Vos described as the lidar industry's shift from a technology-proving phase to a commercialization-focused era...

MicroVision, Inc. develops and commercializes perception solutions for autonomy and mobility applications. It offers product suite, including perception software for industrial, automotive, and defense markets; MAVIN, a MEMS-based long-range sensor capable of small object detection; MOVIA, a flash-based short- to mid-range sensor; lidar sensors for non-automotive industrial markets, such as industrial, smart infrastructure, robotics, and commercial vehicles; and reference and validation software. The company also provides engineering services in connection with hardware and software products, as well as develops custom application software. In addition, it offers industrial and automotive perception systems and advanced driver-assistance systems (ADAS); and MOSAIK suite, a validation software tool for use by OEMs and Tier 1s to validate vehicle sensors for ADAS and autonomous driving applications. The company markets its products to customers directly, through trade shows, and its website. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

Microvision Inc.

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

MVIS
Microvision Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest MVIS News

MVISMicrovision Inc